Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

INS Anjadip commissioning to boost India’s littoral defense capabilities, says GlobalData

INS Anjadip has recently been commissioned into the Indian Navy, marking a significant advancement in India’s coastal defence posture. Aimed at thwarting Chinese and Pakistani submarine intrusion, INS Anjadip and her sister vessels are poised to substantially enhance India’s anti-submarine warfare coverage in the littoral zones, closing capability gaps and improving responsiveness along its maritime […]
Read more

All-season tyres market gains traction amid changing weather patterns and evolving regulations, says GlobalData

In recent years, all-season tyres—specifically those engineered to satisfy both summer and winter performance—including all-weather tyres bearing the 3-Peak Mountain Snowflake (3PMSF) certification—have shifted from a niche solution to a mainstream preference globally. Driven by escalating climate variability, tighter regulations, and heightened sustainability concerns, this segment is not merely growing—it’s redefining expectations of mobility. The […]
Read more

North America leads sports sponsorship spend of hotels and holiday accommodation sector in 2025, reveals GlobalData

Driven by the scale and commercialization of the US and Canadian sports ecosystem, North America led the sports sponsorship spend of the hotel and holiday accommodation sector in 2025. This was largely due to the “big four” leagues, major college sports, and frequent high-attendance tentpole events, which create abundant premium sponsorship inventory and expensive hospitality/experience […]
Read more

Mastercard $1.8 billion BVNK deal signals stablecoins shift to mainstream payment infrastructure, says GlobalData

Stablecoins are moving from crypto’s fringe to the core of global payments as Mastercard has recently agreed to buy BVNK for $1.8 billion, underscoring a strategic pivot toward blockchain-based settlement infrastructure. The deal highlights how payment networks are repositioning to control cross-border money flows, blending faster tokenized settlement with trusted card rails to secure relevance […]
Read more

Posco Future M’s investment highlights Vietnam’s rising role in EV battery materials, says GlobalData

Vietnam is emerging as a preferred manufacturing destination due to its competitive labor and operating costs, improving infrastructure, proximity to major shipping routes, and favorable trade agreements. These advantages are reflected in Posco Future M’s latest move to build an artificial graphite anode facility for electric vehicle (EV) batteries in Thái Nguyên. The project is […]
Read more

Late-stage pipeline to transform progressive pulmonary fibrosis treatment landscape, says GlobalData

Progressive pulmonary fibrosis (PPF) describes a phenotype of non-idiopathic pulmonary fibrosis (IPF) interstitial lung diseases (ILDs) that continues to worsen despite appropriate management, leading to lung scarring, loss of lung function, and early mortality. Current antifibrotic agents slow the rate of forced vital capacity (FVC) decline but do not halt or reverse fibrosis, leaving substantial […]
Read more

India’s minimally invasive glaucoma surgery devices market to grow at 2% CAGR through 2033, forecasts GlobalData

India’s minimally invasive glaucoma surgery (MIGS) devices market is witnessing a steady growth, driven by the rising prevalence of glaucoma and increasing adoption of advanced ophthalmic technologies to improve clinical outcomes. Against this backdrop, the MIGS devices market in India is anticipated to grow at a compound annual growth rate (CAGR) of approximately 2% through […]
Read more

Jab-uary sparks new wave of GLP‑1 friendly food innovation as 27% of consumers open to trying new weight loss drugs, says GlobalData

The rise of “Jab-uary” highlights a transformative moment for the food and drinks industry as injectable GLP-1 drugs such as Ozempic and Wegovy accelerate rapid weight loss adoption, driving demand for tailored nutrition and portion-controlled products. Retailers and food and beverage brands are entering a pivotal new era of product design, as willingness to try […]
Read more

Sasineprocel’s future lies as a monotherapy in Parkinson’s disease, says GlobalData

Sasineprocel’s encouraging Phase I/IIa data positions autologous iPSC-derived dopaminergic neuron therapy as a potential monotherapy challenger in Parkinson’s disease (PD), signaling a shift toward regenerative treatment strategies beyond symptomatic dopamine replacement. Strong safety, graft survival, and functional improvements underscore its disruptive promise, though cost, reimbursement hurdles, and upcoming Phase III validation will determine its real-world […]
Read more

IRLAB’s Phase IIb pirepemat data highlights opportunity in Parkinson’s disease falls management, says GlobalData

Integrative Research Laboratories Sweden AB’s (IRLAB) Phase IIb REACT-PD trial results for pirepemat highlight both the promise and the complexity of targeting non-dopaminergic symptoms in Parkinson’s disease (PD), particularly falls and balance impairment, which remain major unmet needs, says GlobalData, a leading intelligence and productivity platform. Presented at the AD/PD 2026 International Conference, the REACT-PD […]
Read more

Financial institutions face rising IT budgets as they balance innovation, legacy and regulation, says Celent, a GlobalData company

Financial institutions are entering 2026 with competing technology priorities, from scaling artificial intelligence (AI) capabilities and strengthening data governance to modernizing legacy systems and managing rising regulatory demands. While banks and capital market firms are continuing to face pressures on their budgets to maintain the levels of spending on innovation, life insurers are increasing budgets […]
Read more

Weak M&A and private equity drag global deal activity down by 7% YoY in early 2026, reveals GlobalData

Global deal activity began 2026 on a subdued note, with the total number of deals (mergers & acquisitions (M&A), private equity (PE) and venture financing) announced globally decreased by around 7% year-on-year (YoY) during January-February 2026. While some areas of the market showed resilience – most notably venture financing and a strong rebound in China, […]
Read more

Ecnoglutide approval intensifies competition in China GLP-1 obesity market, says GlobalData

China’s approval of Sciwind Biosciences’ Ecnoglutide injection as the fifth GLP-1 obesity therapy signals intensifying competition in one of the world’s fastest-growing metabolic drug markets. Strong Phase III efficacy and a landmark commercialization partnership with Pfizer highlight rising strategic interest in obesity treatments, positioning China as a key battleground for innovation, pricing competition, and global […]
Read more
1 … 27 28 29 30 31 … 784